These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 30543471)
1. Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1. Shaw J; Dale I; Hemsley P; Leach L; Dekki N; Orme JP; Talbot V; Narvaez AJ; Bista M; Martinez Molina D; Dabrowski M; Main MJ; Gianni D SLAS Discov; 2019 Feb; 24(2):121-132. PubMed ID: 30543471 [TBL] [Abstract][Full Text] [Related]
2. High-Throughput Cellular Thermal Shift Assays in Research and Drug Discovery. Henderson MJ; Holbert MA; Simeonov A; Kallal LA SLAS Discov; 2020 Feb; 25(2):137-147. PubMed ID: 31566060 [TBL] [Abstract][Full Text] [Related]
3. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. Tu Y; Tan L; Tao H; Li Y; Liu H Phytomedicine; 2023 Jul; 116():154862. PubMed ID: 37216761 [TBL] [Abstract][Full Text] [Related]
4. High throughput screening of 0.5 million compounds against CRAF using Alpha CETSA Rowlands H; Tschapalda K; Blackett C; Ivanov D; Plant D; Shaw J; Thomas A; Packer M; Arnold L; Holdgate GA SLAS Discov; 2023 Apr; 28(3):102-110. PubMed ID: 36736830 [TBL] [Abstract][Full Text] [Related]
5. A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1. McNulty DE; Bonnette WG; Qi H; Wang L; Ho TF; Waszkiewicz A; Kallal LA; Nagarajan RP; Stern M; Quinn AM; Creasy CL; Su DS; Graves AP; Annan RS; Sweitzer SM; Holbert MA SLAS Discov; 2018 Jan; 23(1):34-46. PubMed ID: 28957646 [TBL] [Abstract][Full Text] [Related]
14. Current Advances in CETSA. Tolvanen TA Front Mol Biosci; 2022; 9():866764. PubMed ID: 35755818 [TBL] [Abstract][Full Text] [Related]
15. Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay. Shaw J; Leveridge M; Norling C; Karén J; Molina DM; O'Neill D; Dowling JE; Davey P; Cowan S; Dabrowski M; Main M; Gianni D Sci Rep; 2018 Jan; 8(1):163. PubMed ID: 29317749 [TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based Cellular Thermal Shift Assay (CETSA®) for target deconvolution in phenotypic drug discovery. Friman T Bioorg Med Chem; 2020 Jan; 28(1):115174. PubMed ID: 31767405 [TBL] [Abstract][Full Text] [Related]
17. Perspective on CETSA Literature: Toward More Quantitative Data Interpretation. Seashore-Ludlow B; Axelsson H; Lundbäck T SLAS Discov; 2020 Feb; 25(2):118-126. PubMed ID: 31665966 [TBL] [Abstract][Full Text] [Related]
18. A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts. Chernobrovkin AL; Cázares-Körner C; Friman T; Caballero IM; Amadio D; Martinez Molina D SLAS Discov; 2021 Apr; 26(4):534-546. PubMed ID: 33445986 [TBL] [Abstract][Full Text] [Related]
19. Early Perspective. Seashore-Ludlow B; Lundbäck T J Biomol Screen; 2016 Dec; 21(10):1019-1033. PubMed ID: 27401582 [TBL] [Abstract][Full Text] [Related]
20. The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies. Martinez Molina D; Nordlund P Annu Rev Pharmacol Toxicol; 2016; 56():141-61. PubMed ID: 26566155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]